Diabetic polyneuropathy not up with impaired glycemia

March 3, 2012
Diabetic polyneuropathy not up with impaired glycemia

(HealthDay) -- Although significantly increased in subjects with new diabetes, the rates of typical diabetic polyneuropathy (DPN), retinopathy, and nephropathy are not significantly different between subjects with and without impaired glycemia (IG), according to research published in the March issue of Diabetes Care.

Peter J. Dyck, M.D., of the Mayo Clinic in Rochester, Minn., and colleagues conducted a prospective, population-based survey of 150 subjects without IG, 174 with IG, and 218 with new diabetes to determine whether DPN, retinopathy, or nephropathy are more prevalent in subjects with IG than in healthy subjects.

The researchers found that the frequency of retinopathy and nephropathy was not significantly different between patients with and without IG, but was greater in those with new diabetes. The frequency of narrowly defined DPN was 2, 1.7, and 7.8 percent in non-IG, IG, and new diabetes subjects, respectively. Using a broader definition, the frequency of DPN was 12.7, 12.6, and 17.4 percent in non-IG, IG, and new diabetes subjects, respectively.

"Prevalence of typical DPN, , and nephropathy was significantly increased only in subjects with new diabetes," the authors write. "For atypical DPN, such an increase was not observed even in subjects with new diabetes. In , explanations other than IG should be sought for patients with atypical DPN (chronic idiopathic axonal polyneuropathy) who have IG."

Explore further: Prediabetes may not explain diabetic polyneuropathies

More information: Abstract
Full Text (subscription or payment may be required)


Related Stories

Prediabetes may not explain diabetic polyneuropathies

February 22, 2012

In a reversal of two decades of medical reports, a Mayo Clinic study finds the frequency of nerve damage called diabetic polyneuropathy is similar in prediabetic patients and healthy people. Physicians should seek explanations ...

Let's stretch... Scientists study myomesin protein

February 14, 2012

The proteins actin, myosin and titin are big players in the business of muscle contraction. Scientists at the European Molecular Biology Laboratory (EMBL) in Hamburg, Germany, have now examined another muscle protein – ...

Recommended for you

Post-biotics may help shield obese from diabetes

April 20, 2017

You've heard of pre-biotics and pro-biotics, but now you'll be hearing a lot more about post-biotics. Researchers at McMaster University have begun to identify how post-biotics, or the by-products of bacteria, lower blood ...

Diabetes continues its relentless rise

April 13, 2017

(HealthDay)—Two new studies on diabetes deliver good and bad news, but the overall message is that the blood sugar disease remains a formidable public health burden.

Researchers unravel how stevia controls blood sugar levels

April 11, 2017

What makes stevia taste so extremely sweet? And how does the sweetener keep our blood sugar level under control? Researchers at KU Leuven (University of Leuven, Belgium) have discovered that stevia stimulates a protein that ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.